The Orientation of a Single Chemical Group Determined Whether Cannabinoid Compounds Were Psychoactive | Research

The takeaway

Molecular modeling revealed that the orientation of one specific chemical group (the C9 substituent) relative to a hydroxyl oxygen predicted whether a cannabinoid compound would be psychoactive or inactive.

Read this if you are interested in the molecular chemistry behind why some cannabinoids are psychoactive and others are not.

One structural feature predicted psychoactivity across six cannabinoid compounds

What the researchers found

Researchers used molecular mechanics calculations to study six cannabinoid compounds with varying levels of psychoactive potency: three active (delta-9-THC, delta-8-THC, and 11-beta-hexahydrocannabinol), one minimally active (11-alpha-HHC), and two inactive (delta-7-THC and delta-9,11-THC).

After optimizing the three-dimensional structures and analyzing ring conformations, they found that all six molecules had nearly identical positions of the key hydroxyl group. The critical difference was in the conformation of the carbocyclic ring, which determined the orientation of the C9 substituent relative to that hydroxyl oxygen.

Active cannabinoids shared a specific geometric relationship between the C9 substituent and the hydroxyl oxygen. When this relationship was disrupted by different ring conformations, the compound became inactive. This suggested that psychoactive potency depends on a precise molecular shape that enables binding to whatever receptor recognizes cannabinoids.

Why it matters

This study provided fundamental insight into the structure-activity relationship of cannabinoids before the cannabinoid receptors were even discovered (CB1 was identified in 1990). Understanding which molecular features produce psychoactivity is essential for designing therapeutic cannabinoids that separate medical benefits from psychoactive effects.

The numbers in context

Six cannabinoid compounds analyzed. Three active, one minimally active, two inactive. Multiple torsion angles measured including C10-C10a-C1-O, C8-C7-C1-O, C11-C9-C1-O, and C9-Q-C1-O.

How the study worked

Computational molecular mechanics study using the MMP2(85) program. Six cannabinoid structures were optimized and their conformations analyzed. Energy profiles for ring conformations and hydroxyl rotations were calculated.

What this study cannot tell us

Computational modeling predicts molecular shapes but cannot confirm actual biological binding mechanisms. The study predated the discovery of cannabinoid receptors, so the target of interaction was unknown. Only six compounds were analyzed.

How to read the evidence

A computational chemistry study providing mechanistic insight. Rigorous within its methodology but predictions require experimental validation.

When this study was published

Published in 1989, one year before the CB1 receptor was discovered. The structural insights gained additional significance once the binding target was identified.

The bigger picture

This molecular modeling work helped lay the groundwork for rational cannabinoid drug design. When the CB1 receptor was discovered the following year, the structural features identified here helped explain why some cannabinoids bind effectively while others do not.

Questions still open

Does the C9 orientation directly affect receptor binding affinity? Can this structural insight be used to design non-psychoactive therapeutic cannabinoids? Do synthetic cannabinoids follow the same structure-activity rules?

Common questions

What makes a cannabinoid psychoactive?

This study found that the orientation of a specific chemical group (C9 substituent) relative to a hydroxyl oxygen on the molecule determined psychoactive potency. Active compounds shared a specific geometric arrangement.

Why does this matter?

Understanding what makes cannabinoids psychoactive at the molecular level is essential for designing therapeutic compounds that provide medical benefits without psychoactive side effects.

Read the original research

The importance of the orientation of the C9 substituent to cannabinoid activity.

Journal of medicinal chemistry, 32(7), 1630-5

View on PubMed ↗

Citation

Reggio, P H; Greer, K V; Cox, S M. (1989). The importance of the orientation of the C9 substituent to cannabinoid activity.. Journal of medicinal chemistry, 32(7), 1630-5.